PDAP1

Across TCGA pan-cancer cohorts, PDAP1 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated PDAP1 data layer compared with 27 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher PDAP1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated PDAP1 expression acts as an unfavorable survival marker.

PAAD are the cancer types where PDAP1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Median	All	0.117	0.613	<.001	21	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

PDAP1–PAAD (OS)

Open the PAAD breakdown →